Isosorbide dinitrate plus hydralazine (ID+H) v placebo for heart failure (HF) in black patients at mean 10 months*
| Outcomes | ID + H | Placebo | 95% CI for the difference | |
|---|---|---|---|---|
| *QOL = quality of life. Lower scores indicate better quality of life. Other abbreviations defined in glossary; RRR, NNT, and CI calculated from data in article. | ||||
| †Composite score (weighted values for all cause death, first hospital admission for HF during 18 mo follow up, and change in quality of life at 6 mo) ranged from −6 to +2, with higher scores indicating better outcome. | ||||
| Mean composite score† | −0.1 | −0.5 | 0.16 to 0.64 | |
| Mean QOL score change at 6 mo | −5.6 | −2.7 | 0.37 to 5.4 | |
| RRR (CI) | NNT (CI) | |||
| All cause death | 6.2% | 10% | 39% (7.7 to 60) | 26 (14 to 150) |
| First hospital admission for HF | 16% | 24% | 33% (14 to 47) | 13 (8 to 32) |